Equities

Anteris Technologies Ltd

Anteris Technologies Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)9.78
  • Today's Change0.78 / 8.67%
  • Shares traded35.81k
  • 1 Year change-51.10%
  • Beta0.5526
Data delayed at least 20 minutes, as of Nov 18 2024 05:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

Anteris Technologies Ltd (AVR:ASX) set a new 52-week low during today's trading session when it reached 8.68. Over this period, the share price is down -50.61%.
52-week range
Today
8.68Nov 18 202423.93Apr 10 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open9.00
High9.83
Low8.68
Bid9.50
Offer9.85
Previous close9.00
Average volume22.50k
Shares outstanding21.14m
Free float18.77m
P/E (TTM)--
Market cap190.26m AUD
EPS (TTM)-5.04
AUD
Data delayed at least 20 minutes, as of Nov 18 2024 05:10 GMT.
More ▼

Events & Activity

  • AVR:ASX trading volume exceeds daily average by +15.04%
  • AVR:ASX price reached a new 52-week low of 9.00 at 18:22 GMT
  • AVR:ASX price moved over -1.10% to 9.00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.